Icon

Medacta Group S.A. Stock Analysis and Price Target COMMON STOCK | | LSE

stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CHF 124.20

-1.81 (-1.43)%

CHF 0.02B

217.00

N/A

N/A

Icon

0A05:LSE

Medacta Group S.A. (CHF)
COMMON STOCK | LSE
CHF 124.20
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CHF 0.02B

N/A

CHF 124.20

Medacta Group S.A. Stock Forecast

N/A

Based on the Medacta Group S.A. stock forecast from 0 analysts, the average analyst target price for Medacta Group S.A. is not available over the next 12 months. Medacta Group S.A.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Medacta Group S.A. is Very Bullish, which is based on 1 positive signals and 0 negative signals. At the last closing, Medacta Group S.A.’s stock price was CHF 124.20. Medacta Group S.A.’s stock price has changed by -1.74% over the past week, +2.81% over the past month and +42.96% over the last year.

No recent analyst target price found for Medacta Group S.A.
No recent average analyst rating found for Medacta Group S.A.

Company Overview Medacta Group S.A.

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The ...Read More

https://www.medacta.com

Strada Regina, 34, Castel San Pietro, Switzerland, 6874

1,537

December

CHF

UK

Adjusted Closing Price for Medacta Group S.A. (0A05:LSE)

Loading...

Unadjusted Closing Price for Medacta Group S.A. (0A05:LSE)

Loading...

Share Trading Volume for Medacta Group S.A. Shares

Loading...

Compare Performance of Medacta Group S.A. Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for 0A05:LSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Medacta Group S.A. (Sector: )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
0R37:LSE
Berkshire Hathaway Inc -7.25 (-1.95%) CHF9,223,372,036.85B N/A N/A

ETFs Containing 0A05

Symbol Name 0A05's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Medacta Group S.A. (0A05:LSE) Stock

Stock Target Advisor's fundamental analysis for Medacta Group S.A.'s stock is Very Bullish.

Unfortunately we do not have enough data on 0A05:LSE's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on 0A05:LSE's stock to indicate what its average analyst target is.

0A05:LSE stock's Price/Earning ratio is 0.47. Based on this 0A05:LSE may be a overvalued for its sector.

The last closing price of 0A05:LSE's stock was CHF 124.20.

The most recent market capitalization for 0A05:LSE is CHF 0.02B.

Unfortunately we do not have enough analyst data on 0A05:LSE's stock to indicate whether its price will go up or not.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...